Regeneration of airway epithelial cells to study rare cell states in cystic fibrosis.
Airway epithelium
Cellular models
Cystic fibrosis
RNA-seq
Repair
Journal
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
ISSN: 1873-5010
Titre abrégé: J Cyst Fibros
Pays: Netherlands
ID NLM: 101128966
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
received:
11
07
2019
revised:
13
09
2019
accepted:
16
09
2019
pubmed:
5
11
2019
medline:
13
10
2021
entrez:
5
11
2019
Statut:
ppublish
Résumé
Pathological remodeling of the airway epithelium is commonly observed in cystic fibrosis (CF). Thus, tissue repair is critical to restore integrity and maintenance of the epithelial barrier function. Epithelial repair is a multi-step process initiated by progenitor cell migration into the injured area, proliferation, and re-differentiation into all of the cell types that contribute to the function of a normal airway epithelium. Recent technological advances applied to relevant animal and cell injury models have helped in understanding the complexity of progenitor cell differentiation. This short review will introduce the current knowledge of the mechanisms regulating airway epithelial cell (AEC) regeneration and repair, with a focus on the specification of two rare cell types/states: ionocytes and deuterosomal cells.
Identifiants
pubmed: 31680046
pii: S1569-1993(19)30894-X
doi: 10.1016/j.jcf.2019.09.010
pii:
doi:
Substances chimiques
Cystic Fibrosis Transmembrane Conductance Regulator
126880-72-6
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
S42-S46Informations de copyright
Copyright © 2019 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest PB, AC, and MC do not have any conflicts of interest relevant to this publication. ABJ and LWP are employees of Novartis Institutes of BioMedical Research. ABJ is a stockholder in Novartis.